Squarepoint Ops LLC Uni Qure N.V. Transaction History

Squarepoint Ops LLC

$96.1 Billion
Q3 2025

A detailed history of Squarepoint Ops LLC transactions in Uni Qure N.V. stock. As of the latest transaction made, Squarepoint Ops LLC holds 181,902 shares of QURE stock, worth $5.44 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

181,902

Previous 176,002 3.35%

Holding current value

$5.44 Million

Previous $2.45 Million 332.82%

% of portfolio

0.01%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$13.28 - $59.4 $78,352 - $350,460	5,900 Added 3.35%	181,902 $10.6 Million
Q2 2025 Aug 27, 2025	SELL	$8.34 - $17.27 $19,432 - $40,239	-2,330 Reduced 1.31%	176,002 $2.45 Million
Q2 2025 Aug 14, 2025	SELL	$8.34 - $17.27 $19,432 - $40,239	-2,330 Reduced 1.31%	176,002 $2.45 Million
Q1 2025 Aug 27, 2025	BUY	$10.6 - $18.08 $24,698 - $42,126	2,330 Added 1.32%	178,332 $1.89 Million
Q1 2025 May 15, 2025	BUY	$10.6 - $18.08 $1.74 Million - $2.96 Million	163,745 Added 1122.54%	178,332 $1.89 Million

Q4 2024 Feb 14, 2025	SELL	$4.54 - $17.73 $42,866 - $167,406	-9,442 Reduced 39.29%	14,587 $257,000
Q3 2024 Nov 14, 2024	BUY	$3.78 - $10.12 $90,829 - $243,173	24,029 New	24,029 $118,000
Q4 2023 Feb 14, 2024	BUY	$5.63 - $8.27 $497,720 - $731,109	88,405 Added 328.8%	115,292 $780,000
Q2 2023 Aug 14, 2023	BUY	$11.12 - $22.2 $298,983 - $596,891	26,887 New	26,887 $308,000
Q1 2022 May 16, 2022	SELL	$14.54 - $21.5 $296,383 - $438,256	-20,384 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$20.24 - $36.01 $412,572 - $734,027	20,384 New	20,384 $423,000
Q3 2021 Nov 15, 2021	SELL	$26.01 - $38.22 $876,849 - $1.29 Million	-33,712 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$29.97 - $37.17 $36,353 - $45,087	1,213 Added 3.73%	33,712 $1.04 Million
Q1 2021 May 17, 2021	BUY	$29.24 - $42.03 $655,151 - $941,724	22,406 Added 222.0%	32,499 $1.1 Million
Q4 2020 Feb 16, 2021	SELL	$35.35 - $50.67 $948,900 - $1.36 Million	-26,843 Reduced 72.67%	10,093 $365,000
Q3 2020 Nov 16, 2020	BUY	$35.98 - $47.66 $1.33 Million - $1.76 Million	36,936 New	36,936 $1.36 Million
Q2 2020 Aug 14, 2020	SELL	$45.06 - $67.74 $277,344 - $416,939	-6,155 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$40.01 - $73.97 $534,413 - $988,017	-13,357 Reduced 68.46%	6,155 $292,000
Q4 2019 Feb 14, 2020	BUY	$37.13 - $74.62 $158,433 - $318,403	4,267 Added 27.99%	19,512 $1.4 Million
Q3 2019 Nov 14, 2019	SELL	$39.36 - $76.8 $868,084 - $1.69 Million	-22,055 Reduced 59.13%	15,245 $600,000
Q2 2019 Aug 14, 2019	BUY	$52.76 - $82.19 $726,716 - $1.13 Million	13,774 Added 58.55%	37,300 $2.92 Million
Q1 2019 May 15, 2019	BUY	$27.39 - $68.41 $224,817 - $561,509	8,208 Added 53.58%	23,526 $1.4 Million
Q4 2018 Feb 14, 2019	SELL	$22.8 - $33.93 $251,780 - $374,688	-11,043 Reduced 41.89%	15,318 $441,000
Q3 2018 Nov 14, 2018	SELL	$29.75 - $43.08 $1.06 Million - $1.53 Million	-35,556 Reduced 57.43%	26,361 $959,000
Q2 2018 Aug 14, 2018	BUY	$21.96 - $39.94 $526,425 - $957,441	23,972 Added 63.18%	61,917 $2.34 Million
Q1 2018 May 15, 2018	BUY	$17.1 - $26.61 $648,859 - $1.01 Million	37,945 New	37,945 $892,000

Others Institutions Holding QURE

# of Institutions

267

Shares Held

51.1M

Call Options Held

3.92M

Put Options Held

View Full List

About uniQure N.V.

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $1.4B
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

More about QURE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Account

Squarepoint Ops LLC Uni Qure N.V. Transaction History